Related Experiment Video
Updated: Aug 2, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
New prospects for cardiovascular gene therapy
1Targeted Genetics Corp., 1100 Olive Way, Suite 100, Seattle, WA 98101, USA. lynchc@targen.com
Abstract:
Cardiovascular gene therapy has been hampered by the lack of suitable gene delivery vectors for in vivo applications. Low transduction efficiencies, lack of persistent transgene expression and undesirable inflammatory and immune responses have limited the prospects for human gene therapy in the cardiovascular system. New prospects for cardiovascular gene therapy are a result of recent vector developments, in particular with the use of adeno-associated virus (AAV) based vectors in the heart and peripheral vasculature.
Related Concept Videos
Gene Therapy
Pharmacogenomics: Identification of New Drug Targets

